Real-time enrollment status for this phenylketonuria (pku) clinical trial
Current Status
Recruiting
Checked: August 27, 2026 at 10:32 AM UTC
| NCT Number | NCT06628128 |
| Recruiting Status | Recruiting |
| Condition | Phenylketonuria (PKU) |
| Phase | PHASE3 |
| Target Enrollment | 240 participants |
| Active Locations | 8 sites in the US |
| Sponsor | Otsuka Pharmaceutical Development & Commercialization, Inc. |
| Last Updated on CT.gov | May 1, 2026 (May 1, 2026) |
As of August 27, 2026: Clinical trial NCT06628128 is currently recruiting participants. This phase3 study for phenylketonuria (pku) is actively seeking new participants at 8 locations across the United States. The study is sponsored by Otsuka Pharmaceutical Development & Commercialization, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06628128 is actively recruiting participants as of August 27, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 8 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06628128 was last updated May 1, 2026 (May 1, 2026). HelloStudys verifies this status automatically.